Skip to main content
Top

Open Access 11-05-2024 | Cytostatic Therapy | REVIEW

Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review

Authors: Eran Ben-Arye, Noah Samuels, Georg Seifert, Orit Gressel, Raviv Peleg, Miek Jong

Published in: Current Oncology Reports

Login to get access

Abstract

Purpose of the review

Children and adolescents with cancer, along with their parents and other informal caregivers, often report using complementary and alternative medicine (CAM) during active oncology and hemato-oncology treatment. Some adopt an “alternative” approach to conventional medical care, which often entails the use of these practices without the knowledge of the treating pediatrician. In contrast, many others search for consultation provided by a pediatric integrative oncology (IO) practitioner working with the conventional medical team. IO seeks to provide evidence-based complementary medicine therapies, many of which have been shown to augment conventional supportive and palliative care, while ensuring the patient’s safety. The present narrative review examines the current state of and future direction for the IO setting of care.

Recent findings

A large body of published clinical research supports the effectiveness of leading Pediatric IO modalities, while addressing potential safety-related concerns.

Summary

Despite the growing amount of clinical research supporting the beneficial effects and implementation of Pediatric IO models of care, there is still a need for further studies in order to establish clinical guidelines in the treatment of children and adolescents with cancer. Such IO-directed guidelines will need to address both the effectiveness and the safety of the CAM modalities being used in pediatric oncology and hemato-oncology settings, promoting a better understanding among pediatric healthcare professionals and helping them understand the indications for referral to the IO treatment service.
Literature
1.
go back to reference National Cancer Institute: Complementary and Alternative Medicine (CAM) - NCI (cancer.gov) June 12, 2023 Accessed 6 December 2023 National Cancer Institute: Complementary and Alternative Medicine (CAM) - NCI (cancer.gov) June 12, 2023 Accessed 6 December 2023
7.
go back to reference WHO Traditional, Complementary and Integrative Medicine. Accessed 6 December 2023 URL link Traditional, Complementary and Integrative Medicine (who.int) WHO Traditional, Complementary and Integrative Medicine. Accessed 6 December 2023 URL link Traditional, Complementary and Integrative Medicine (who.int)
13.
14.
go back to reference Olbara G, Parigger J, Njuguna F, Skiles J, Sitaresmi MN, Gordijn S, van de Ven P, Kaspers G, Mostert S. Health-care providers’ perspectives on traditional and complementary alternative medicine of childhood cancer in Kenya. Pediatr Blood Cancer. 2018;65(12):e27309. https://doi.org/10.1002/pbc.27309.CrossRefPubMed Olbara G, Parigger J, Njuguna F, Skiles J, Sitaresmi MN, Gordijn S, van de Ven P, Kaspers G, Mostert S. Health-care providers’ perspectives on traditional and complementary alternative medicine of childhood cancer in Kenya. Pediatr Blood Cancer. 2018;65(12):e27309. https://​doi.​org/​10.​1002/​pbc.​27309.CrossRefPubMed
15.
go back to reference • Bishop FL, Prescott P, Chan YK, Saville J, von Elm E, Lewith GT. Prevalence of complementary medicine use in pediatric cancer: a systematic review. Pediatrics. 2010;125(4):768–76. https://doi.org/10.1542/peds.2009-1775. (In this systematic review the authors summarize the evidence on the prevalence of complementary medicine use in pediatric patients with cancer and assess the reported quality of included studies.)CrossRefPubMed • Bishop FL, Prescott P, Chan YK, Saville J, von Elm E, Lewith GT. Prevalence of complementary medicine use in pediatric cancer: a systematic review. Pediatrics. 2010;125(4):768–76. https://​doi.​org/​10.​1542/​peds.​2009-1775. (In this systematic review the authors summarize the evidence on the prevalence of complementary medicine use in pediatric patients with cancer and assess the reported quality of included studies.)CrossRefPubMed
19.
go back to reference Menut V, Seigneur E, Gras Leguen C, Orbach D, Thebaud E. Utilisation des médecines complémentaires et alternatives chez l’enfant et l’adolescent atteint de cancer : une pratique fréquente [Complementary and alternative medicine use in two French pediatric oncology centers: A common practice]. Bull Cancer. 2019;106(3):189–200. French. https://doi.org/10.1016/j.bulcan.2018.11.017. Menut V, Seigneur E, Gras Leguen C, Orbach D, Thebaud E. Utilisation des médecines complémentaires et alternatives chez l’enfant et l’adolescent atteint de cancer : une pratique fréquente [Complementary and alternative medicine use in two French pediatric oncology centers: A common practice]. Bull Cancer. 2019;106(3):189–200. French. https://​doi.​org/​10.​1016/​j.​bulcan.​2018.​11.​017.
23.
go back to reference • Schütze T, Längler A, Zuzak TJ, Schmidt P, Zernikow B. Use of complementary and alternative medicine by pediatric oncology patients during palliative care. Support Care Cancer. 2016;24(7):2869–75. https://doi.org/10.1007/s00520-016-3097-2. (The study provides information about usage of complementary and alternative medicine in children suffering from cancer during the palliative phase of the disease)CrossRefPubMed • Schütze T, Längler A, Zuzak TJ, Schmidt P, Zernikow B. Use of complementary and alternative medicine by pediatric oncology patients during palliative care. Support Care Cancer. 2016;24(7):2869–75. https://​doi.​org/​10.​1007/​s00520-016-3097-2. (The study provides information about usage of complementary and alternative medicine in children suffering from cancer during the palliative phase of the disease)CrossRefPubMed
27.
30.
go back to reference Susilawati D, Sitaresmi M, Handayani K, Ven PV, Kaspers G, Mostert S. HealthCare Providers’ and parents’ perspectives on complementary alternative medicine in children with Cancer in Indonesia. Asian Pac J Cancer Prev. 2016;17(7):3235–42.PubMed Susilawati D, Sitaresmi M, Handayani K, Ven PV, Kaspers G, Mostert S. HealthCare Providers’ and parents’ perspectives on complementary alternative medicine in children with Cancer in Indonesia. Asian Pac J Cancer Prev. 2016;17(7):3235–42.PubMed
33.
go back to reference • Stub T, Kristoffersen AE, Overvåg G, Jong MC. An integrative review on the information and communication needs of parents of children with cancer regarding the use of complementary and alternative medicine. BMC Complement Med Ther. 2020;20(1):90. https://doi.org/10.1186/s12906-020-02882-y. (The study reviews the literature as to identify the information and communication needs of parents of children with cancer, and the children themselves, regarding the use of complementary medicine.)CrossRefPubMedPubMedCentral • Stub T, Kristoffersen AE, Overvåg G, Jong MC. An integrative review on the information and communication needs of parents of children with cancer regarding the use of complementary and alternative medicine. BMC Complement Med Ther. 2020;20(1):90. https://​doi.​org/​10.​1186/​s12906-020-02882-y. (The study reviews the literature as to identify the information and communication needs of parents of children with cancer, and the children themselves, regarding the use of complementary medicine.)CrossRefPubMedPubMedCentral
38.
go back to reference Pirson L, Lüer SC, Diezi M, Kroiss S, Brazzola P, Schilling FH, von der Weid N, Scheinemann K, Greiner J, Zuzak TJ, von Bueren AO. Pediatric oncologists’ perspectives on the use of complementary medicine in pediatric cancer patients in Switzerland: A national survey-based cross-sectional study. Cancer Rep (Hoboken). 2023;6(1):e1649. https://doi.org/10.1002/cnr2.1649.CrossRefPubMed Pirson L, Lüer SC, Diezi M, Kroiss S, Brazzola P, Schilling FH, von der Weid N, Scheinemann K, Greiner J, Zuzak TJ, von Bueren AO. Pediatric oncologists’ perspectives on the use of complementary medicine in pediatric cancer patients in Switzerland: A national survey-based cross-sectional study. Cancer Rep (Hoboken). 2023;6(1):e1649. https://​doi.​org/​10.​1002/​cnr2.​1649.CrossRefPubMed
42.
go back to reference Mao JJ, Ismaila N, Bao T, Barton D, Ben-Arye E, Garland EL, Greenlee H, Leblanc T, Lee RT, Lopez AM, Loprinzi C, Lyman GH, MacLeod J, Master VA, Ramchandran K, Wagner LI, Walker EM, Bruner DW, Witt CM, Bruera E. Integrative medicine for pain management in oncology: society for integrative oncology-ASCO guideline. J Clin Oncol. 2022;40(34):3998–4024. https://doi.org/10.1200/JCO.22.01357.CrossRefPubMed Mao JJ, Ismaila N, Bao T, Barton D, Ben-Arye E, Garland EL, Greenlee H, Leblanc T, Lee RT, Lopez AM, Loprinzi C, Lyman GH, MacLeod J, Master VA, Ramchandran K, Wagner LI, Walker EM, Bruner DW, Witt CM, Bruera E. Integrative medicine for pain management in oncology: society for integrative oncology-ASCO guideline. J Clin Oncol. 2022;40(34):3998–4024. https://​doi.​org/​10.​1200/​JCO.​22.​01357.CrossRefPubMed
43.
go back to reference Greenlee H, DuPont-Reyes MJ, Balneaves LG, Carlson LE, Cohen MR, Deng G, Johnson JA, Mumber M, Seely D, Zick SM, Boyce LM, Tripathy D. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA: Cancer J Clin. 2017;67:194–232. https://doi.org/10.3322/caac.21397.CrossRefPubMed Greenlee H, DuPont-Reyes MJ, Balneaves LG, Carlson LE, Cohen MR, Deng G, Johnson JA, Mumber M, Seely D, Zick SM, Boyce LM, Tripathy D. Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment. CA: Cancer J Clin. 2017;67:194–232. https://​doi.​org/​10.​3322/​caac.​21397.CrossRefPubMed
44.
go back to reference Carlson LE, Ismaila N, Addington EL, Asher GN, Atreya C, Balneaves LG, Bradt J, Fuller-Shavel N, Goodman J, Hoffman CJ, Huston A, Mehta A, Paller CJ, Richardson K, Seely D, Siwik CJ, Temel JS, Rowland JH. Integrative oncology care of symptoms of anxiety and depression in adults with cancer: society for integrative Oncology-ASCO guideline. J Clin Oncol. 2023;41(28):4562–91. https://doi.org/10.1200/JCO.23.00857.CrossRefPubMed Carlson LE, Ismaila N, Addington EL, Asher GN, Atreya C, Balneaves LG, Bradt J, Fuller-Shavel N, Goodman J, Hoffman CJ, Huston A, Mehta A, Paller CJ, Richardson K, Seely D, Siwik CJ, Temel JS, Rowland JH. Integrative oncology care of symptoms of anxiety and depression in adults with cancer: society for integrative Oncology-ASCO guideline. J Clin Oncol. 2023;41(28):4562–91. https://​doi.​org/​10.​1200/​JCO.​23.​00857.CrossRefPubMed
47.
go back to reference • Mora DC, Overvåg G, Jong MC, Kristoffersen AE, Stavleu DC, Liu J, Stub T. Complementary and alternative medicine modalities used to treat adverse effects of anti-cancer treatment among children and young adults: a systematic review and meta-analysis of randomized controlled trials. BMC Complement Med Ther. 2022;22(1):97. https://doi.org/10.1186/s12906-022-03537-w. (This meta-analysis of randomized controlled trials shows that acupuncture and hypnosis are effective in reducing chemotherapy-induced nausea and vomiting in children and young adults)CrossRefPubMedPubMedCentral • Mora DC, Overvåg G, Jong MC, Kristoffersen AE, Stavleu DC, Liu J, Stub T. Complementary and alternative medicine modalities used to treat adverse effects of anti-cancer treatment among children and young adults: a systematic review and meta-analysis of randomized controlled trials. BMC Complement Med Ther. 2022;22(1):97. https://​doi.​org/​10.​1186/​s12906-022-03537-w. (This meta-analysis of randomized controlled trials shows that acupuncture and hypnosis are effective in reducing chemotherapy-induced nausea and vomiting in children and young adults)CrossRefPubMedPubMedCentral
48.
go back to reference Lopes-Júnior LC, Urbano IR, Schuab SIPC, Pessanha RM, Rosa GS, Lima RAG. Effectiveness of complementary therapies for the management of symptom clusters in palliative care in pediatric oncology: a systematic review. Rev Esc Enferm USP. 2021;55:03709. English, Portuguese. https://doi.org/10.1590/S1980-220X2020025103709. Lopes-Júnior LC, Urbano IR, Schuab SIPC, Pessanha RM, Rosa GS, Lima RAG. Effectiveness of complementary therapies for the management of symptom clusters in palliative care in pediatric oncology: a systematic review. Rev Esc Enferm USP. 2021;55:03709. English, Portuguese. https://​doi.​org/​10.​1590/​S1980-220X202002510370​9.
52.
54.
go back to reference Pillai AK, Sharma KK, Gupta YK, Bakhshi S. Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy. Pediatr Blood Cancer. 2011;56(2):234–8.CrossRefPubMed Pillai AK, Sharma KK, Gupta YK, Bakhshi S. Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy. Pediatr Blood Cancer. 2011;56(2):234–8.CrossRefPubMed
55.
go back to reference Daneshfard B, Shahriari M, Heiran A, Nimrouzi M, Yarmohammadi H. Effect of chamomile on chemotherapy-induced neutropenia in pediatric leukemia patients: A randomized triple-blind placebo-controlled clinical trial. Avicenna J Phytomed. 2020;10(1):58–69.PubMedPubMedCentral Daneshfard B, Shahriari M, Heiran A, Nimrouzi M, Yarmohammadi H. Effect of chamomile on chemotherapy-induced neutropenia in pediatric leukemia patients: A randomized triple-blind placebo-controlled clinical trial. Avicenna J Phytomed. 2020;10(1):58–69.PubMedPubMedCentral
59.
go back to reference Zhang XJ, Yan M, Liu Y, Wang XM, Nuriding H. Effects of Huangqi injection on infection factors in children with acute lymphoblastic leukemia. Zhongguo Dang Dai Er Ke Za Zhi. 2014;16(2):147–51 (Chinese).PubMed Zhang XJ, Yan M, Liu Y, Wang XM, Nuriding H. Effects of Huangqi injection on infection factors in children with acute lymphoblastic leukemia. Zhongguo Dang Dai Er Ke Za Zhi. 2014;16(2):147–51 (Chinese).PubMed
60.
go back to reference Shi X, Zhu XD, Wang HM. Effects of fuzheng jianpi decoction combined chemotherapy on the quality of life and the survival time of children with solid tumor. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012;32(9):1175–9 (Chinese).PubMed Shi X, Zhu XD, Wang HM. Effects of fuzheng jianpi decoction combined chemotherapy on the quality of life and the survival time of children with solid tumor. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012;32(9):1175–9 (Chinese).PubMed
61.
go back to reference Shi X, Liu ZM, Zhu XD. Treatment of vomiting in children patients with solid tumor by hewei zhiou recipe combined ondansetron hydrochloride. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012;32(4):468–70 (Chinese).PubMed Shi X, Liu ZM, Zhu XD. Treatment of vomiting in children patients with solid tumor by hewei zhiou recipe combined ondansetron hydrochloride. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012;32(4):468–70 (Chinese).PubMed
62.
go back to reference Seifert G, Blakeslee SB, Calaminus G, Kandil FI, Barth A, Bernig T, Classen CF, Corbacioglu S, Föll J, Gottschling S, Gruhn B, Vom Hoff-Heise C, Lode HN, Martin D, Nathrath M, Neunhoeffer F, Pekrun A, Wulff B, Zuzak T, Henze G, Längler A. Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up. BMC Cancer. 2022;22(1):652. https://doi.org/10.1186/s12885-022-09703-0.CrossRefPubMedPubMedCentral Seifert G, Blakeslee SB, Calaminus G, Kandil FI, Barth A, Bernig T, Classen CF, Corbacioglu S, Föll J, Gottschling S, Gruhn B, Vom Hoff-Heise C, Lode HN, Martin D, Nathrath M, Neunhoeffer F, Pekrun A, Wulff B, Zuzak T, Henze G, Längler A. Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up. BMC Cancer. 2022;22(1):652. https://​doi.​org/​10.​1186/​s12885-022-09703-0.CrossRefPubMedPubMedCentral
68.
go back to reference Ward E, Smith M, Henderson M, Reid U, Lewis I, Kinsey S, et al. The effect of high-dose enteral glutamine on the incidence and severity of mucositis in paediatric oncology patients. Eur J Clin Nutr. 2009;63(1):134–40.CrossRefPubMed Ward E, Smith M, Henderson M, Reid U, Lewis I, Kinsey S, et al. The effect of high-dose enteral glutamine on the incidence and severity of mucositis in paediatric oncology patients. Eur J Clin Nutr. 2009;63(1):134–40.CrossRefPubMed
69.
go back to reference El-Housseiny AA, Saleh SM, El-Masry AA, Allam AA. The effectiveness of vitamin "E" in the treatment of oral mucositis in children receiving chemotherapy. J Clin Pediatr Dent. 2007 Spring;31(3):167–70. El-Housseiny AA, Saleh SM, El-Masry AA, Allam AA. The effectiveness of vitamin "E" in the treatment of oral mucositis in children receiving chemotherapy. J Clin Pediatr Dent. 2007 Spring;31(3):167–70.
74.
go back to reference Reyna-Figueroa J, Barrón-Calvillo E, García-Parra C, Galindo-Delgado P, Contreras-Ochoa C, Lagunas-Martínez A, Campos-Romero FH, Silva-Estrada JA, Limón-Rojas AE. Probiotic Supplementation Decreases Chemotherapy-induced Gastrointestinal Side Effects in Patients With Acute Leukemia. J Pediatr Hematol Oncol. 2019;41(6):468–72. https://doi.org/10.1097/MPH.0000000000001497.CrossRefPubMed Reyna-Figueroa J, Barrón-Calvillo E, García-Parra C, Galindo-Delgado P, Contreras-Ochoa C, Lagunas-Martínez A, Campos-Romero FH, Silva-Estrada JA, Limón-Rojas AE. Probiotic Supplementation Decreases Chemotherapy-induced Gastrointestinal Side Effects in Patients With Acute Leukemia. J Pediatr Hematol Oncol. 2019;41(6):468–72. https://​doi.​org/​10.​1097/​MPH.​0000000000001497​.CrossRefPubMed
75.
go back to reference Eghbali A, Ghaffari K, Khalilpour A, Afzal RR, Eghbali A, Ghasemi A. The effects of LactoCare synbiotic administration on chemotherapy-induced nausea, vomiting, diarrhea, and constipation in children with ALL: A double-blind randomized clinical trial. Pediatr Blood Cancer. 2023;70(6):e30328. https://doi.org/10.1002/pbc.30328.CrossRefPubMed Eghbali A, Ghaffari K, Khalilpour A, Afzal RR, Eghbali A, Ghasemi A. The effects of LactoCare synbiotic administration on chemotherapy-induced nausea, vomiting, diarrhea, and constipation in children with ALL: A double-blind randomized clinical trial. Pediatr Blood Cancer. 2023;70(6):e30328. https://​doi.​org/​10.​1002/​pbc.​30328.CrossRefPubMed
76.
go back to reference Vieira ML, Fonseca FL, Costa LG, Beltrame RL, Chaves CM, Cartum J, Alves SI, Azzalis LA, Junqueira VB, Pereria EC, Rocha KC. Supplementation with selenium can influence nausea, fatigue, physical, renal, and liver function of children and adolescents with cancer. J Med Food. 2015;18(1):109–17. https://doi.org/10.1089/jmf.2014.0030.CrossRefPubMed Vieira ML, Fonseca FL, Costa LG, Beltrame RL, Chaves CM, Cartum J, Alves SI, Azzalis LA, Junqueira VB, Pereria EC, Rocha KC. Supplementation with selenium can influence nausea, fatigue, physical, renal, and liver function of children and adolescents with cancer. J Med Food. 2015;18(1):109–17. https://​doi.​org/​10.​1089/​jmf.​2014.​0030.CrossRefPubMed
78.
go back to reference Carlson LE, Ismaila N, Addington EL, Asher GN, Atreya C, Balneaves LG, Bradt J, Fuller-Shavel N, Goodman J, Hoffman CJ, Huston A, Mehta A, Paller CJ, Richardson K, Seely D, Siwik CJ, Temel JS, Rowland JH. Integrative oncology care of symptoms of anxiety and depression in adults with cancer: society for integrative oncology-ASCO guideline. J Clin Oncol. 2023;41(28):4562–91. https://doi.org/10.1200/JCO.23.00857.CrossRefPubMed Carlson LE, Ismaila N, Addington EL, Asher GN, Atreya C, Balneaves LG, Bradt J, Fuller-Shavel N, Goodman J, Hoffman CJ, Huston A, Mehta A, Paller CJ, Richardson K, Seely D, Siwik CJ, Temel JS, Rowland JH. Integrative oncology care of symptoms of anxiety and depression in adults with cancer: society for integrative oncology-ASCO guideline. J Clin Oncol. 2023;41(28):4562–91. https://​doi.​org/​10.​1200/​JCO.​23.​00857.CrossRefPubMed
79.
go back to reference Mao JJ, Ismaila N, Bao T, Barton D, Ben-Arye E, Garland EL, Greenlee H, Leblanc T, Lee RT, Lopez AM, Loprinzi C, Lyman GH, MacLeod J, Master VA, Ramchandran K, Wagner LI, Walker EM, Bruner DW, Witt CM, Bruera E. Integrative medicine for pain management in oncology: society for integrative oncology-ASCO guideline. J Clin Oncol. 2022;40(34):3998–4024. https://doi.org/10.1200/JCO.22.01357.CrossRefPubMed Mao JJ, Ismaila N, Bao T, Barton D, Ben-Arye E, Garland EL, Greenlee H, Leblanc T, Lee RT, Lopez AM, Loprinzi C, Lyman GH, MacLeod J, Master VA, Ramchandran K, Wagner LI, Walker EM, Bruner DW, Witt CM, Bruera E. Integrative medicine for pain management in oncology: society for integrative oncology-ASCO guideline. J Clin Oncol. 2022;40(34):3998–4024. https://​doi.​org/​10.​1200/​JCO.​22.​01357.CrossRefPubMed
86.
go back to reference Pourtsidis A, Doganis D, Baka M, Varvoutsi M, Bouhoutsou D, Xatzi P, Kosmidis H. Prayer and blessings focused for healing is the most popular complementary intervention in a paediatric oncology unit in Greece. J Buon. 2015;20(2):602–7.PubMed Pourtsidis A, Doganis D, Baka M, Varvoutsi M, Bouhoutsou D, Xatzi P, Kosmidis H. Prayer and blessings focused for healing is the most popular complementary intervention in a paediatric oncology unit in Greece. J Buon. 2015;20(2):602–7.PubMed
88.
go back to reference Jacknow DS, Tschann JM, Link MP, Boyce WT. Hypnosis in the prevention of chemotherapy-related nausea and vomiting in children: a prospective study. J Dev Behav Pediatr. 1994;15(4):258–64.CrossRefPubMed Jacknow DS, Tschann JM, Link MP, Boyce WT. Hypnosis in the prevention of chemotherapy-related nausea and vomiting in children: a prospective study. J Dev Behav Pediatr. 1994;15(4):258–64.CrossRefPubMed
89.
go back to reference Zeltzer LK, Dolgin MJ, LeBaron S, LeBaron C. A randomized, controlled study of behavioral intervention for chemotherapy distress in children with cancer. Pediatrics. 1991;88(1):34–42.PubMed Zeltzer LK, Dolgin MJ, LeBaron S, LeBaron C. A randomized, controlled study of behavioral intervention for chemotherapy distress in children with cancer. Pediatrics. 1991;88(1):34–42.PubMed
96.
106.
107.
go back to reference Van der Gucht K, Takano K, Labarque V, Vandenabeele K, Nolf N, Kuylen S, Cosyns V, Van Broeck N, Kuppens P, Raes F. A mindfulness-based intervention for adolescents and young adults after cancer treatment: effects on quality of life, emotional distress, and cognitive vulnerability. J Adolesc Young Adult Oncol. 2017;6(2):307–17. https://doi.org/10.1089/jayao.2016.0070.CrossRefPubMed Van der Gucht K, Takano K, Labarque V, Vandenabeele K, Nolf N, Kuylen S, Cosyns V, Van Broeck N, Kuppens P, Raes F. A mindfulness-based intervention for adolescents and young adults after cancer treatment: effects on quality of life, emotional distress, and cognitive vulnerability. J Adolesc Young Adult Oncol. 2017;6(2):307–17. https://​doi.​org/​10.​1089/​jayao.​2016.​0070.CrossRefPubMed
108.
116.
go back to reference Lopes-Júnior LC, Urbano IR, Schuab SIPC, Pessanha RM, Rosa GS, Lima RAG. Effectiveness of complementary therapies for the management of symptom clusters in palliative care in pediatric oncology: a systematic review. Rev Esc Enferm USP. 2021 May 19;55:03709. English, Portuguese. https://doi.org/10.1590/S1980-220X2020025103709 Lopes-Júnior LC, Urbano IR, Schuab SIPC, Pessanha RM, Rosa GS, Lima RAG. Effectiveness of complementary therapies for the management of symptom clusters in palliative care in pediatric oncology: a systematic review. Rev Esc Enferm USP. 2021 May 19;55:03709. English, Portuguese. https://​doi.​org/​10.​1590/​S1980-220X202002510370​9
118.
go back to reference Ibashtawy M, Gharaibeh H, Alhalaiqa F, Batiha AM, Freij M, Saifan A, Al-Awamreh K, Hamadneh S, Al-Kloub M, Khamaiseh A. The health belief model’s impacts on the use of complementary and alternative medicine by parents or guardians of children with cancer. Iran J Public Health. 2016;45(5):708–9. Ibashtawy M, Gharaibeh H, Alhalaiqa F, Batiha AM, Freij M, Saifan A, Al-Awamreh K, Hamadneh S, Al-Kloub M, Khamaiseh A. The health belief model’s impacts on the use of complementary and alternative medicine by parents or guardians of children with cancer. Iran J Public Health. 2016;45(5):708–9.
119.
121.
go back to reference Längler A, Spix C, Gottschling S, Graf N, Kaatsch P. Elternbefragung zur Anwendung alternativer und komplementärer Behandlungsmethoden in der Kinderonkologie in Deutschland [Parents-interview on use of complementary and alternative medicine in pediatric oncology in Germany]. Klin Padiatr. 2005;217(6):357-64. German.https://doi.org/10.1055/s-2005-872522 Längler A, Spix C, Gottschling S, Graf N, Kaatsch P. Elternbefragung zur Anwendung alternativer und komplementärer Behandlungsmethoden in der Kinderonkologie in Deutschland [Parents-interview on use of complementary and alternative medicine in pediatric oncology in Germany]. Klin Padiatr. 2005;217(6):357-64. German.https://​doi.​org/​10.​1055/​s-2005-872522
129.
go back to reference •• Mao JJ, Pillai GG, Andrade CJ, Ligibel JA, Basu P, Cohen L, Khan IA, Mustian KM, Puthiyedath R, Dhiman KS, Lao L, Ghelman R, Cáceres Guido P, Lopez G, Gallego-Perez DF, Salicrup LA. Integrative oncology: Addressing the global challenges of cancer prevention and treatment. CA Cancer J Clin. 2022;72(2):144–64. https://doi.org/10.3322/caac.21706. (Remarkable paper co-authored by the Society for Integrative Oncology on the global challenges of addressing integrative oncology in cancer prevention and treatment)CrossRefPubMed •• Mao JJ, Pillai GG, Andrade CJ, Ligibel JA, Basu P, Cohen L, Khan IA, Mustian KM, Puthiyedath R, Dhiman KS, Lao L, Ghelman R, Cáceres Guido P, Lopez G, Gallego-Perez DF, Salicrup LA. Integrative oncology: Addressing the global challenges of cancer prevention and treatment. CA Cancer J Clin. 2022;72(2):144–64. https://​doi.​org/​10.​3322/​caac.​21706. (Remarkable paper co-authored by the Society for Integrative Oncology on the global challenges of addressing integrative oncology in cancer prevention and treatment)CrossRefPubMed
130.
131.
go back to reference Sari NM, Devansyah S, Modjaningrat I, Suryawan N, Susanah S, Rakhmillah L, Wahyudi K, Kaspers GJL. Type of cancer and complementary and alternative medicine are determinant factors for the patient delay experienced by children with cancer: A study in West Java, Indonesia. Pediatr Blood Cancer. 2023;70(4):e30192. https://doi.org/10.1002/pbc.30192.CrossRefPubMed Sari NM, Devansyah S, Modjaningrat I, Suryawan N, Susanah S, Rakhmillah L, Wahyudi K, Kaspers GJL. Type of cancer and complementary and alternative medicine are determinant factors for the patient delay experienced by children with cancer: A study in West Java, Indonesia. Pediatr Blood Cancer. 2023;70(4):e30192. https://​doi.​org/​10.​1002/​pbc.​30192.CrossRefPubMed
Metadata
Title
Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review
Authors
Eran Ben-Arye
Noah Samuels
Georg Seifert
Orit Gressel
Raviv Peleg
Miek Jong
Publication date
11-05-2024
Publisher
Springer US
Published in
Current Oncology Reports
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-024-01538-1
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine